Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..."
 
Vol 11, No 6 (2015) Pleiotropic effects of statins. Are there opportunities to explain of the phenomenon? Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, I. Z. Rakhmatullin, V. V. Klochkov, A. V. Aganov
"... A hypothesis that possible pleiotropic features of different statins could be explained ..."
 
Vol 7, No 6 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA Abstract  similar documents
V. P. Voronina, S. N. Tolpygina, N. P. Kutishenko, N. A. Dmitrieva, Yu. V. Lukina, S. Yu. Martsevich
"... гиполипидемическому эффекту соответствует оригинальному симвастатину , т.е. является терапевтически эквивалентным. ..."
 
Vol 9, No 4 (2013) STATINS AND THE RISK OF DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina
"... Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction ..."
 
Vol 8, No 3 (2012) STATINS AND MYOPATHY: MOLECULAR MECHANISMS Abstract  similar documents
O. M. Drapkina, E. M. Chernova, O. N. Korneeva
"... The safety of statin therapy is considered. In particular the reasons of a complication ..."
 
Vol 9, No 4 (2013) STATINS IN PREVENTION OF ISCHEMIC STROKE Abstract  similar documents
A. V. Susekov, A. B. Blohin, Z. G. Luginova, E. J. Soloveva, N. V. Maltseva, O. E. Tarasova, V. V. Kuharchuk
"... The evidence base of statin therapy in primary and secondary prevention of ischemic stroke ..."
 
Vol 13, No 4 (2017) GENETIC PREDICTORS OF INTENSIVE LIPID-LOWERING THERAPY EFFICACY AND ITS ANTI-INFLAMMATORY EFFECTS IN VERY HIGH CARDIOVASCULAR RISK PATIENTS Abstract  similar documents
M. A. Vorobyeva, M. M. Azova, O. O. Gigani, I. V. Garmash, S. V. Villevalde, Zh. D. Kobalava
"... lipid-lowering therapy and can be considered as a predictor of resistance to statins.  ..."
 
Vol 7, No 6 (2011) CURRENT ETIOTROPIC DIAGNOSTICS AND RATIONAL ANTIBACTERIAL THERAPY OF INFECTIVE ENDOCARDITIS Abstract  similar documents
V. G. Seyidov, B. G. Andryukov
"... Представлены современные принципы диагностики и лечения инфекционного эндокардита. Обсуждаются ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... Questions of statins use in liver diseases are discussed. Data from clinical studies on statins ..."
 
Vol 11, No 1 (2015) MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT Abstract  similar documents
O. M. Drapkina, E. M. Chernova
"... Statins are lipid-lowering drugs with proven efficacy that reduce cardiovascular risk and are well ..."
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... ), non-alcoholic steatohepatitis (NASH) and hypercholesterolemia (HCE) with statins and ursodeoxycholic ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... group II (n=32) did not take statins. The duration of follow-up was 4 years. The evolution of the AF ..."
 
Vol 5, No 6 (2009) STATIN GENERICS: EFFICACY AND SAFETY RATIO Abstract  similar documents
V. P. Voronina, A. A. Serazhim, A. V. Zagrebelnyi, S. Yu. Martsevich, S. A. Shalnova
"... Statin usage for primary and secondary prevention of cardiovascular diseases is focused. Rational ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... Background. Effects of statins on cardiovascular end points are well-known. To study the impact ..."
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The main indications to statins and principles of statin usage on the basis of International ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... Various aspects of the safety of statins in clinical practice are discussed: hepatotoxicity ..."
 
Vol 5, No 4 (2009) PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... The definition of primary prevention of cardiovascular diseases is presented. Statins preventive ..."
 
Vol 3, No 1 (2007) MICROCIRCULATORY ISCHEMIA AND STATINS: LESSONS OF INTERVENTION CARDIOLOGY Abstract  similar documents
An. A. Alexandrov, I. I. Tchukaeva
"... . Therapy by statins can be beneficial for patients with microcirculatory ischemia. ..."
 
Vol 2, No 2 (2006) PROBLEM OF TREATMENT WITH STATINS IN RUSSIA: WILL GENERICS HELP? Abstract  similar documents
S. Y. Martsevich
"... The article underlines necessity of statins treatment for patients with high risk of cardio ..."
 
Vol 8, No 5 (2012) LIPID-LOWERING EFFICACY OF ROSUVASTATIN COMPARED WITH OTHER STATINS Abstract  similar documents
A. N. Meshkov
"... of the study of rosuvastatin therapy efficacy , in comparison with other statins, received in controlled ..."
 
Vol 12, No 5 (2016) Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis Abstract  similar documents
M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov
"... . Negative correlation between the statins receiving and serum endothelin level was found in men (r=-0.11; p ..."
 
Vol 11, No 4 (2015) TREATMENT OF PATIENTS WITH SEVERE DYSLIPIDEMIA IN REAL CLINICAL PRACTICE Abstract  similar documents
V. A. Korneva, T. Yu. Kuznetsova, E. S. Karpova, K. I. Rupasova
"... cholesterol >9 mmol/l) the frequency of statins prescription in 2009-2012 was 70%. In 28.9% of the patients ..."
 
Vol 10, No 5 (2014) STATINS IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES: REPETITION OF THE PAST AND OPTIMISM FOR THE FUTURE Abstract  similar documents
L. N. Malay
"... Statins, the most common drugs for reduction in lipid levels, are “strategic” medicinal products ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
"... The evidences for statin use in cardiology are presented. Especially hypolipidemic efficacy ..."
 
Vol 1, No 3 (2005) RHEUMATOID ARTHRITIS AND CARDIOVASCULAR RISK: PERSPECTIVES OF TREATMENT WITH STATINS Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... . The perspectives of treatments with statins in RA are given. Results of clinical trials on statin effects ..."
 
Vol 10, No 4 (2014) STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN Abstract  similar documents
N. G. Gogolashvili
"... анализ результатов этих исследова- ний показал более выраженный эффект статинов, чем в когорте ЧКВ в ..."
 
Vol 10, No 5 (2014) STATINS USE IN THE PERIOPERATIVE PERIOD ACCORDING TO THE EVIDENCE-BASED MEDICINE Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... been focused on statins use. Evidence base of this drugs class use in the perioperative period serves ..."
 
Vol 6, No 6 (2010) COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE Abstract  similar documents
S. V. Shalaev, Z. M. Safiullina, L. V. Kremneva, O. V. Abaturova
"... function, ability to reduce the blood level of C-reactive protein are important in the statins mode ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... in patients with CVD risk factors, of course, are statins. The results of multi-center studies showing ..."
 
Vol 11, No 5 (2015) Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation Abstract  similar documents
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
"... proatherogenic blood profile was observed in both groups. The patients of MTX group more frequently took statins ..."
 
Vol 14, No 5 (2018) Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome Abstract  PDF (Eng)  similar documents
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal
"... , инсульт и побочные эффекты. Результаты. При поступлении пациенты  обеих  групп были сопоставимы по ..."
 
Vol 5, No 2 (2009) OBSERVATIONAL TRAILS IN LIPIDOLOGY Abstract  similar documents
S. A. Shalnova
"... and observational trails are presented. The trail data on statins efficacy and safety are held up as a model. ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... Aim. To assess of lipid-lowering therapy with statins in very high cardiovascular risk patients ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... for statins use. Material and methods. Patients (n=262, age 60.1±8.9 years) took statins for secondary ..."
 
Vol 13, No 4 (2017) HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE? Abstract  similar documents
I. S. Yavelov, M. V. Zhatkina, O. M. Drapkina, A. Yu. Gorshkov, N. O. Myasnikova
"... statins in high doses before percutaneous coronary interventions (PCI) are presented in the review ..."
 
Vol 1, No 2 (2005) STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY Abstract  similar documents
Y. A. Karpov
"... , aswell as problems of statin treatment safety. The choice of the drug must be based on clinical research ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... , статины. Рациональная фармакотерапия в кардиологии 2015;11(5):504-509 Three-year dynamics and unsolved ..."
 
Vol 9, No 5 (2013) THE ROLE OF LIPOTROPIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE BEFORE AND AFTER CORONARY REVASCULARIZATION Abstract  similar documents
R. N. Adzhiev, M. S. Safarova, M. V. Ezhov
"... , Post-CABG, TNT) and meta-analyzes on the role of statins, prescribed before and after coronary artery ..."
 
Vol 12, No 2 (2016) PLEIOTROPIC EFFECTS OF VITAMIN D Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... витамина D с детальным описанием патогенетических путей реализации указанных эффектов.  С учетом данных ..."
 
Vol 2, No 4 (2006) POSTMENOPAUSAL METABOLIC SYNDROME: CORRECTION OF AUTONOMIC NERVOUS SYSTEM DISBALANCE WITH COMBINATION OF ACE-INHIBITOR AND STATIN Abstract  similar documents
I. V. Logacheva, E. N. Shustova, E. V. Kulinich
"... (ACE inhibitor and statin), not only have antihypertensive and hypolipidemic action, but also reduce ..."
 
Vol 13, No 2 (2017) STATINS AND THEIR INTERACTION WITH MODEL CELL MEMBRANES ACCORDING TO THE DATA OF NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY Abstract  similar documents
I. A. Latfullin, L. F. Galiullina, G. S. Musabirova, O. V. Aganova, Z. F. Kim, A. V. Aganov, V. V. Klochkov
"... interatomic distances between the atoms of statins and micelles. Material and methods. Nuclear magnetic ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 4, No 3 (2008) DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY Abstract  similar documents
E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin
"... барорефлек- торной чувствительности [32]. Кроме того, статины ока- зывают благоприятный эффект в отношении ..."
 
Vol 7, No 3 (2011) STROKE PREVENTION IN INTERNIST PRACTICE Abstract  similar documents
D. A. Napalkov, A. V. Zhilenko
"... guidelines. Modern pharmacotherapy includes antiaggregants or anticoagulants, statins, and antihypertensive ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... .39%, statins – 69.45%). When assessing prescribed doses of drugs, an increase in a number of their higher doses ..."
 
Vol 10, No 6 (2014) DIAGNOSIS AND TREATMENT OF PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA IN REAL OUTPATIENT PRACTICE (ACCORDING TO THE RECVASA REGISTRY) Abstract  similar documents
A. I. Ershova, A. N. Meshkov, S. S. Yakushin, M. M. Loukianov, K. A. Moseychuk, S. Yu. Martsevich, A. V. Zagrebelnyy, A. N. Vorobyev, K. G. Pereverzeva, E. A. Pravkina, A. N. Kozminskiy, S. A. Boytsov
"... hypercholesterolemia were classified as patients at high or very high cardiovascular risk, but statins were recommended ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... Aim. To assess the risk factors of statin-associated muscle damage in patient with ischemic heart ..."
 
Vol 4, No 4 (2008) LOVASTATIN EFFECT ON VASCULAR REMODELING AND MYOCARDIAL SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. S. Kerimkulova, A. M. Noruzbaeva, O. S. Lunegova, B. Z. Imanov, M. A. Pavlenko, A. E. Mirrahimov, I. JU. Gottfried, E. M. Mirrahimov
"... -месячного периода лечения ловастатином в 1-й группе наряду с гиполипидемическим эффектом выявлены снижение ..."
 
Vol 14, No 3 (2018) HYPOLIPIDEMIC THERAPY IN STROKE PREVENTION: EXISTING STANDARDS, EVIDENCE-BASED MEDICINE DATA AND REAL PRACTICE Abstract  similar documents
O. V. Gaisenok, A. N. Rozhkov, A. S. Lishuta
"... . The issues of lipid-lowering therapy with statins in the aspect of stroke prevention are discussed ..."
 
Vol 14, No 4 (2018) Statin Therapy and Cognitive Impairment: Benefit or Harm? Abstract  similar documents
O. D. Ostroumova, E. V. Chikh, E. V. Rebrova, A. Yu. Ryazanova
"... Statins are now widely used drugs for the treatment of dyslipidemia, effective drugs for lowering ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... Aim. To study the opinion of doctors about the possibility of statins prescription to patients ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... Chronic non-infectious diseases are characterized by irregular morbidity and mortality throughout ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... антитромбоцитарных свойств статинов, их связь со стимуляцией продукции оксида азота, мощного эндогенного ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... Russian physicians often afraid to use statins in patients with high cardiovascular risk ..."
 
Vol 7, No 3 (2011) REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 Abstract  similar documents
N. V. Perova
"... Comparative dose-dependent ability of different statins to lower serum low-density lipoproteins ..."
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 9, No 6 (2013) APPLIED ASPECTS OF SLCO1B1 PHARMACOGENETIC TESTING FOR PREDICTING OF STATIN-INDUCED MYOPATHY AND PERSONALIZATION OF STATINS THERAPY Abstract  similar documents
D. A. Sychev, G. N. Shuev, A. B. Prokofiev
"... polipeptide) in the development of statin induced myopathy is considered. Possible tactics of statin dose ..."
 
Vol 14, No 6 (2018) Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues Abstract  PDF (Eng)  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan
"... on a low number of patients taking statins, and even less – reaching recommended target cholesterol levels ..."
 
Vol 11, No 2 (2015) HYPOLIPIDEMIC THERAPY IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN 2004-2010 ACCORDING TO THE PROGNOZ IBS REGISTER Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... Aim. To evaluate the frequency of prescription, efficacy and patients adherence to statin therapy ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... Current views on the efficacy criteria of hyperlipidaemia treatment with statins are considered ..."
 
Vol 2, No 1 (2006) DEGENERATIVE AORTIC STENOSIS: PATHOGENESIS AND NEW PRINCIPLES OF TREATMENT Abstract  similar documents
O. V. Andropova, V. N. Anokhin
"... воспаления, ингибиторы ангиотензинпревращающего фермента, статины РФК 2006; 1: 31-36 Degenerative aortic ..."
 
Vol 11, No 3 (2015) ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, O. N. Tkacheva, A. S. Lishuta
"... was significantly above the target and varied from 5.82 to 6.10 mmol/L. At that, statins had not been prescribed ..."
 
Vol 9, No 2 (2013) MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina
"... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... using Propensity Score Matching. Material and methods. 262 patients aged 60.1±8.9 years, taking statins ..."
 
Vol 11, No 1 (2015) ALL-RUSSIA RESEARCH/PRACTICE CONFERENCE “NON-INFECTIOUS DISEASES AND PUBLIC HEALTH IN RUSSIA” 28-29 MAY 2015, MOSCOW Abstract  similar documents
"... факторов риска на здо- ровье населения 3. Популяционные технологии профилактики не- инфекционных ..."
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
"... , атеросклероз, фиброз, диабетическая кардиомиопатия, статины, бета-блокаторы, ингибиторы АПФ, тиазолидиндионы ..."
 
Vol 7, No 1 (2011) EXPERT CONCLUSION OF THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION, RUSSIAN NATIONAL SOCIETY OF ATHEROSCLEROSIS, RUSSIAN SOCIETY OF CARDIOSOMATIC REHABILITATION AND SECONDARY PREVENTION ON STATIN THERAPY OPTIMIZATION IN CLINICAL PRACTICE  similar documents
"... событий более чем на 1/3. Существующие сего- дня в арсенале врачей статины (ловастатин, праваста- тин ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... Цель. Сравнить гипотензивный и метаболические эффекты, а также влияние на эректильную функцию (ЭФ ..."
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... максимальной дозе, несмотря на доказанный гиполипидемический эффект препарата. ..."
 
Vol 8, No 6 (2012) ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE Abstract  similar documents
A. I. Chesnikova, V. A. Safronenko, A. V. Hripun
"... of myocardial infarction (MI) depending on the statin therapy compliance. Material and methods. Patients (n=31 ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... intake and not appropriate BP self-monitoring. Low frequency of statins therapy and non-targeted ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... (CVD) was significantly less (17) compared with non-vaccinated (38), р=0.03. The risk of infectious ..."
 
Vol 6, No 6 (2010) GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) Abstract  similar documents
Gilbert Habib, Bruno Hoen, Pilar Tornos, Franck Thuny, Bernard Prendergast, Isidre Vilacosta, Philippe Moreillon, Manuel de Jesus Antunes, Ulf Thilen, John Lekakis, Maria Lengyel, Ludwig Muller, Christoph K. Naber, Petros Nihoyannopoulos, Anton Moritz, Jose Luis Zamorano, M. O. Evseev
"... ИНФЕКЦИОННОГО ЭНДОКАРДИТА (НОВАЯ ВЕРСИЯ 2009 ГОДА) Рабочая группа Европейского общества кардиологов (ESC ..."
 
Vol 7, No 1 (2011) TIMING OF PRE-OPERATIVE BETA-BLOCKER TREATMENT IN VASCULAR SURGERY PATIENTS: INFLUENCE ON POST-OPERATIVE OUTCOME  similar documents
W.-J. Flu, J.-P. van Kuijk, M. Chonchol, T. A. Winkel, H.J.M. Verhagen, J. J. Bax, D. Poldermans
"... -БЛОКАТОРАМИ И ЭФФЕКТ НА ИСХОД ОПЕРАЦИИ НА СОСУДАХ W.-J. Flu1, J.-P. van Kuijk1, M. Chonchol2, T.A. Winkel3, H ..."
 
Vol 13, No 6 (2017) SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS Abstract  similar documents
I. N. Ozerova, V. A. Metelskaya, N. E. Gavrilova
"... lipoproteins in men and women with coronary atherosclerosis treated with statins depending on low density ..."
 
Vol 13, No 3 (2017) ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING Abstract  similar documents
A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya
"... metabolism and biochemical safety of statin use were analyzed. The duration of observation of results ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... %, соответственно). Максимальный эффект отмечен у больных с впервые выявленным СД и целевыми показателями липидов ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, beta-blockers ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... .3%, statins – up to 45.6%. Despite of no changes registered in prescription rate of the ACE inhibitors, marked ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... Aim. To study adherence to treatment with generic statins prescribed to patients with high and very ..."
 
Vol 14, No 5 (2018) Clinical Case: Tuberculous Myopericarditis in the Cardiology Practice Abstract  similar documents
A. I. Skripka, A. V. Buchneva, V. V. Vankhin, N. V. Lisyanskaya, V. V. Babyre, P. V. Senchikhin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... is that  pericarditis might be a sign of many infectious and non-infectious diseases. It is quite difficult to define ..."
 
Vol 6, No 5 (2010) THE INFECTIVE ENDOCARDITIS (PREVENTION, DIAGNOSIS CRITERIA AND TREATMENT): KEY POINTS 2010 Abstract  similar documents
A. A. Demin
"... инфекционного эндокардита, подготовленные Рабочей группой Европейского общества кардиологов (ESC) в 2009 г., и ..."
 
Vol 15, No 4 (2019) Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis Abstract  PDF (Eng)  similar documents
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova
"... За последние 30 лет частота инфекционного эндокардита (ИЭ) возросла в 3 раза. Заболеваемость ИЭ ..."
 
Vol 14, No 2 (2018) MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov
"... randomized into two groups: the first group included 43 patients who received high-dose statin therapy ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Цель. Сравнить гипотензивный и метаболические эффекты длительной терапии, основанной на ..."
 
Vol 5, No 1 (2009) CLINICAL EFFECT OF TESTOSTERONE IN MEN WITH STABLE ANGINA Abstract  similar documents
A. Ya. Kravchenko, V. M. Provotorov
"... и не сопровождалась развитием значимых побочных эффектов.  ..."
 
Vol 10, No 5 (2014) RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME Abstract  similar documents
N. V. Perova, V. A. Metelskaya
"... of dyslipidemia correction. The use of statins as lipid-lowering therapy in patients with acute coronary syndrome ..."
 
Vol 10, No 1 (2014) CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part I (Diagnostics) Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova
"... study infectious-immune myocarditis was found in 78.9% of IA and 66.7% of DCM-patients, arrhythmogenic ..."
 
Vol 10, No 2 (2014) CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) Abstract  similar documents
O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova
"... study infectious-immune myocarditis was found in 78.9% patients with IA and 66.7% patients with DCM ..."
 
Vol 9, No 2 (2013) EFFECT OF CHOLESTEROL BLOOD LEVEL REDUCTION BEGINNING EARLY IN LIFE ON THE RISK OF ISCHEMIC HEART DISEASE Abstract  similar documents
N. V. Perova
"... - ронарной реваскуляризации. В другом исследовании клинический эффект лечения статинами оценивали по данным ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... сердечной недостаточности (СН), после перенесенного ИМ можно говорить о класс-эффекте при этих заболева ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... антиагрегантный эффект. Целью исследования является оценка влияния активности изофермента CYP3A4 и полиморфных ..."
 
Vol 8, No 3 (2012) CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova
"... мероприятий оказывает кардиопротективный эффект у больных ИБС, перенесших ЧКВ и имеющих ДД ишемического генеза. ..."
 
Vol 8, No 1 (2012) URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL  similar documents
S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker
"... 110 Рациональная Фармакотерапия в Кардиологии 2012;8(1) ЭФФЕКТ УРСОДЕОКСИХОЛЕВОЙ КИСЛОТЫ У БОЛЬНЫХ ..."
 
Vol 4, No 3 (2008) URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES Abstract  similar documents
M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov
"... Цель. Сравнить уродинамические эффекты бета-адреноблокаторов (БАБ) различной селективности ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
"... Statin intake is a standard in the treatment of patients with atherosclerosis nowadays ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... .4% of the IHD patients received no medications. Statins intake increased from 5.3% to 85.7% in men and from 9 ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... время как эффект БРА является менее определенным. Материал и методы. В мета-анализ было включено 26 ..."
 
1 - 100 of 1112 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)